{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:45:28Z","timestamp":1787503528390,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.neuroscience.2008.08.030","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T08:44:39Z","timestamp":1219913079000},"page":"1005-1016","source":"Crossref","is-referenced-by-count":29,"title":["Negative effects of chronic oral chlorpromazine and olanzapine treatment on the performance of tasks designed to assess spatial learning and working memory in rats"],"prefix":"10.1016","volume":"156","author":[{"suffix":"Jr.","given":"A.V.","family":"Terry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.E.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vandenhuerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Mahadik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2008.08.030_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archpsyc.1988.01800250095013","article-title":"Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses","volume":"45","author":"Baldessarini","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib2","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.lfs.2005.11.031","article-title":"Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer","volume":"78","author":"Barth","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/exnr.2000.7397","article-title":"On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis","volume":"163","author":"Bartus","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-3565(25)11335-9","article-title":"Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells","volume":"260","author":"Bolden","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.pnpbp.2003.09.008","article-title":"Muscarinic mechanisms of antipsychotic atypicality","volume":"27","author":"Bymaster","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.biopsych.2005.08.009","article-title":"Decreased encoding efficiency in schizophrenia","volume":"59","author":"Cairo","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0924-977X(95)00047-S","article-title":"Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels","volume":"6","author":"Chetty","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1970.01740280001001","article-title":"Chlorpromazine plasma levels and effects","volume":"22","author":"Curry","year":"1970","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/syn.890070209","article-title":"The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory","volume":"7","author":"Decker","year":"1991","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2006.05.021","article-title":"Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment","volume":"542","author":"Didriksen","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib11","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1503\/cmaj.1041064","article-title":"Modern antipsychotic drugs: a critical overview","volume":"172","author":"Gardner","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00007691-200302000-00007","article-title":"Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication","volume":"25","author":"Gex-Fabry","year":"2003","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","article-title":"Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the \u201cright stuff\u201d?","volume":"26","author":"Green","year":"2000","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1176\/appi.ajp.164.7.992","article-title":"Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions","volume":"164","author":"Green","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib15","series-title":"Cognition in schizophrenia: Impairments, importance, and treatment strategies","first-page":"73","article-title":"Learning and memory in schizophrenia","author":"Gur","year":"2000"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4088\/JCP.v65n0312","article-title":"Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness","volume":"65","author":"Harvey","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib17","first-page":"197","article-title":"Spontaneously hypertensive rats: Further evaluation of age-related memory performance and cholinergic marker expression","volume":"28","author":"Hernandez","year":"2003","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.neuroscience.2008.08.030_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0920-9964(95)00027-J","article-title":"A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia","volume":"17","author":"Keefe","year":"1995","journal-title":"Schizophr Res"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0091-3057(87)90523-5","article-title":"Chronic haloperidol effects on oral movements and radial-arm maze performance in rats","volume":"26","author":"Levin","year":"1987","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0091-3057(97)00052-X","article-title":"Chronic haloperidol administration does not block acute nicotine-induced improvements in radial-arm maze performance in the rat","volume":"58","author":"Levin","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1037\/0735-7044.109.4.579","article-title":"Hippocampal and nonhippocampal contributions to place learning in rats","volume":"109","author":"McDonald","year":"1995","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0165-0173(93)90006-L","article-title":"The neuropharmacological and neurochemical basis of place learning in the Morris water maze","volume":"18","author":"McNamara","year":"1993","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0924-977X(99)00021-8","article-title":"Some behavioural effects of risperidone in rats: comparison with haloperidol","volume":"9","author":"Nowakowska","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.neuroscience.2008.08.030_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0028-3932(79)90042-3","article-title":"Spatial memory and hippocampal function","volume":"17","author":"Olton","year":"1979","journal-title":"Neuropsychologia"},{"issue":"3","key":"10.1016\/j.neuroscience.2008.08.030_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0006-3223(98)00370-9","article-title":"Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study","volume":"46","author":"Park","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00004714-200102000-00004","article-title":"Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial","volume":"21","author":"Perry","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-2001-19184","article-title":"Olanzapine: pharmacology, pharmacokinetics and therapeutic drug monitoring","volume":"69","author":"Rao","year":"2001","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0278-5846(02)00221-X","article-title":"The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in 3- and eighteen-month-old rats","volume":"26","author":"Rosengarten","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.mp.4000336","article-title":"Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors","volume":"3","author":"Seeman","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/schbul\/sbi007","article-title":"Learning potential and the prediction of work skill acquisition in schizophrenia","volume":"31","author":"Sergi","year":"2005","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0306-4522(00)00569-8","article-title":"Dahl-salt sensitive and salt-resistant rats: examination of learning and memory performance, blood pressure, and the expression of central nicotinic-acetylcholine receptors","volume":"103","author":"Terry","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00213-002-1230-z","article-title":"Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats","volume":"164","author":"Terry","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.npp.1300039","article-title":"Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats","volume":"28","author":"Terry","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuroscience.2005.08.006","article-title":"Chronic exposure to typical or atypical antipsychotics in rodents: Temporal effects on central alpha 7 nicotinic acetylcholine receptors","volume":"136","author":"Terry","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00213-004-2114-1","article-title":"Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys","volume":"179","author":"Terry","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.105.099218","article-title":"Time dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats","volume":"318","author":"Terry","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib40","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.neuroscience.2007.03.003","article-title":"Oral haloperidol or risperidone treatment in rats: Temporal effects on nerve growth factor receptors, cholinergic neurons, and memory performance","volume":"146","author":"Terry","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.neuroscience.2007.09.014","article-title":"Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats","volume":"150","author":"Terry","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib42","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1124\/jpet.106.106047","article-title":"Time dependent cognitive deficits associated with first and second generation antipsychotics: cholinergic dysregulation as a potential mechanism","volume":"320","author":"Terry","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib43","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0091-3057(88)90413-3","article-title":"Thigmotaxis as a test for anxiolytic activity in rats","volume":"31","author":"Treit","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0893-133X(98)00072-4","article-title":"M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats","volume":"20","author":"Varty","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib45","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00213-006-0347-x","article-title":"Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys","volume":"188","author":"Von Huben","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00213-003-1398-x","article-title":"Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats","volume":"167","author":"Winstanley","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib47","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/rcm.2914","article-title":"Liquid chromatography\/tandem mass spectrometry for the simultaneous determination of olanzipine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat plasma","volume":"21","author":"Zhang","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.neuroscience.2008.08.030_bib48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jchromb.2007.03.045","article-title":"Sensitive liquid chromatography\/tandem mass spectrometry method for the determination of the lipophilic antipsychotic drug chlorpromazine in rat plasma and brain tissue","volume":"854","author":"Zhang","year":"2007","journal-title":"J Chromatogr B"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452208012396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452208012396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T13:26:22Z","timestamp":1738329982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452208012396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0306452208012396"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2008.08.030","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}